Systemic Delivery of Tumor-Targeting siRNA Nanoparticles against an Oncogenic LncRNA Facilitates Effective Triple-Negative Breast Cancer Therapy

Long non-coding RNAs (lncRs), by virtue of their versatility and multilevel gene regulation, have emerged as attractive pharmacological targets for treating heterogenous and complex malignancies like triple-negative breast cancer (TNBC). Despite multiple studies on lncRNA functions in tumor patholog...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Bioconjug Chem
Asıl Yazarlar: Vaidya, Amita M, Sun, Zhanhu, Ayat, Nadia, Schilb, Andrew, Liu, Xujie, Jiang, Hongfa, Sun, Da, Scheidt, Josef, Qian, Victoria, He, Siyuan, Gilmore, Hannah, Schiemann, William P., Lu, Zheng-Rong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6820053/
https://ncbi.nlm.nih.gov/pubmed/30739442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.bioconjchem.9b00028
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller